Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Vaxart, Inc. (VXRT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 5.69 million shares as of 2023-06-30, per its 10-Q filed 2023-08-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2023-08-03
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 5.69M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 5.88M shares.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 5.42M shares.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 4.94M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2023-06-30 | 5.69M shares 10-Q · filed 2023-08-03 |
| 2022-12-31 | 5.88M shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 5.42M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 4.94M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 4.51M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 9.58M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 3.67M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 3.49M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 3.01M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 6.50M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 2.54M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 1.43M shares 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |